Toyo Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.75 M
as on 09-12-2024
- Paid Up Capital ₹ 0.73 M
as on 09-12-2024
- Company Age 40 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.01 M
as on 09-12-2024
- Revenue -11.38%
(FY 2019)
- Profit 63.36%
(FY 2019)
- Ebitda 111.22%
(FY 2019)
- Net Worth 38.76%
(FY 2019)
- Total Assets 3.70%
(FY 2019)
About Toyo Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.75 M and a paid-up capital of Rs 0.73 M.
The company currently has active open charges totaling ₹6.01 M.
Prabha Nagarsekar, Devidas Nagarsekar, Nikita Talauliker, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232GA1984PTC000596
- Company No.
000596
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Oct 1984
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Toyo Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devidas Nagarsekar  | Managing Director | 22-Oct-1984 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prabha Nagarsekar | Director | 22-Oct-1984 | Current |
| Nikita Talauliker | Whole-Time Director | 01-Jul-2015 | Current |
| Suvidha Kantak | Whole-Time Director | 01-Jul-2015 | Current |
Financial Performance of Toyo Laboratories.
Toyo Laboratories Pvt Ltd, for the financial year ended 2019, experienced significant reduction in revenue, with a 11.38% decrease. The company also saw a substantial improvement in profitability, with a 63.36% increase in profit. The company's net worth Soared by an impressive increase of 38.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Toyo Laboratories?
In 2019, Toyo Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 17 Jun 2020 | ₹2.93 M | Open |
State Bank Of India Creation Date: 17 Feb 1992 | ₹2.48 M | Open |
State Bank Of India Creation Date: 01 Feb 1991 | ₹0.27 M | Open |
How Many Employees Work at Toyo Laboratories?
Toyo Laboratories has a workforce of 16 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Toyo Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Toyo Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
